| Project/Area Number |
13557062
|
|---|
| Research Category |
Grant-in-Aid for Scientific Research (B)
|
| Allocation Type | Single-year Grants |
|---|
| Section | 展開研究 |
|---|
| Research Field |
Circulatory organs internal medicine
|
|---|
| Research Institution | The University of Tokyo |
|---|
Principal Investigator |
OUCHI Yasuyoshi The University of Tokyo, Faculty of Medicine, Professor, 医学部附属病院, 教授 (80168864)
|
|---|
| Co-Investigator(Kenkyū-buntansha) |
OHIKE Yumiko The University of Tokyo, Faculty of Medicine, Assistant, 医学部附属病院, 教務職員 (20359615)
KOZAKI Koichi The University of Tokyo, Faculty of Medicine, Professor, 医学部附属病院, 講師 (80272540)
INOUE Satoshi The University of Tokyo, Faculty of Medicine, Professor, 医学部附属病院, 講師 (40251251)
WATANABE Tokurnitsu The University of Tokyo, Faculty of Medicine, Medical Staff, 医学部附属病院, 医員
飯島 勝矢 東京大学, 医学部附属病院, 助手 (00334384)
|
|---|
| Project Period (FY) |
2001 – 2003
|
| Project Status |
Completed (Fiscal Year 2003)
|
| Budget Amount *help |
¥9,800,000 (Direct Cost: ¥9,800,000)
Fiscal Year 2003: ¥2,600,000 (Direct Cost: ¥2,600,000)
Fiscal Year 2002: ¥3,500,000 (Direct Cost: ¥3,500,000)
Fiscal Year 2001: ¥3,700,000 (Direct Cost: ¥3,700,000)
|
|---|
| Keywords | estrogen receptor / vascular smooth muscle cells / adeno virus vector / DNA chip / 動脈硬化 / エストロゲン / ラロキシフェン / ERα / ERβ / マイクロアレイ / 卵巣摘除 / トランジェニックラット / 骨量 |
|---|
| Research Abstract |
The goal of our study is to elucidate the atheroprotective effects of estrogen, especially the role of estrogen receptor (ER) subtype, and to apply a new therapeutic method using ER to prevent atherosclerosis. We have gained six results for the three years, described below. (1) We found that low dose of estrogen suppressed neointima formation after balloon-injury in rat carotid arteries. This suppressive effect was comparable to that of angiotensin II type 1 receptor blocker, candesartan. (2) We examined which ER subtype was involved in the inhibitoiy effect of estrogen on vascular smooth muscle cell proliferation using adenovirus-mediated overexpression of ERα and β. We found that the inhibitoiy effect was mediated mainly via ERβ through the downregulation of cyclin A. (3) We observed that estrogen inhibited the proliferation of cardiac fibroblasts via both ERα and ERβ. (4) Using microarray analysis, we identified four genes (caveolin-1, enigma, SmLIM and Id3a), which were highly expr
… More
essed in aortic media in response to hormone replacement therapy. (5) Apoptosis of vascular endothelium is supposed to be related to the initiation of atherosclerotic lesion. We showed that estrogen as well as raloxifen attenuated endothelial apoptosis induced by hydrogen peroxide. This effect was mediated, in part, through the downregulation of Bax expression. (6) Obesity is one of the important risk factors for atherosclerosis, and estrogen has anti-obese effect. We found that the mechanism of the inhibitory effect of estrogen is through ERβ expressed in the central nervous system. (7) We successfully constructed transgenic mouse overexpressing mutant ER which has a dominant negative transcriptional activity to both ERα and ERβ. Neointima was formed in this mouse by placing polyethylene cuff around the femoral artery. By this method, we were able to clarify the biophysical effect of ER. (8) We found that hormone replacement therapy using half ordinary dose of estrogen improved flow dependent vasodilatory response and suppressed the progression of carotid intima-media thickening in postmenopausal female patients. Less
|
